Editor's note: Every morning, James Altucher presents the most timely, topical posts from the Web's best business blogs.

Sirius ( SIRI) hits the 52-week low list again.


A Dash of Insight gives the complete lowdown on Transocean ( RIG). Transocean was also covered in this weekend's Barron's article on offshore drillers.


Stockpickr's System trades of the day include trades triggering this morning on Taser International ( TASR) and JetBlue ( JBLU).


Carl Icahn is on fire this year. Motorola ( MOT) simply should not fear him.


If you're looking for the next Dendreon ( DNDN), here are the biotech stocks with the greatest short interest, including AtheroGenics ( AGIX) and Coley ( COLY). They also all have a significant clinical event in the near future.


Seeking Alpha has some interesting arbitrage ideas: short Amazon ( AMZN), long eBay ( EBAY). And short Yahoo! ( YHOO), long Google ( GOOG).


The best way to find stocks that are breaking out is to check out the stocks that rose yesterday on unusual volume.


Trader Mike asks : Does Dow 13,000 mean everyone is richer?


Portfolio.com wants to know whether Google paid too much for Doubleclick.


If Google seems high to you, just forget about shorting it.


Yes, it's true. Someone bought this domain name for $12.9 million, and it was worth it.


Buffetteer believes that Lasik surgery provider LCA-Vision ( LCAV) should get a lot more focus from investors.


With the baby boom getting older, the demand for products and services from "death stocks" is practically guaranteed to increase. Here are a few stocks that may prosper from the aging of the American population.


Commodity Equity gives a lesson on why sugar is the next bull market and suggests one stock to play it.


Wow, the executives of Schering-Plough ( SGP) spend a lot of money protecting themselves from PETA.


This is the strangest YouTube story that I've heard.


Here's an interesting collection of stocks trading for more than $100.


At the time of publication, Altucher and/or his fund had no positions in any of the stocks mentioned, although positions may change at any time.

James Altucher is a managing partner at Formula Capital, an alternative asset management firm that runs several quantitative-based hedge funds as well as a fund of hedge funds. He is also the author of Trade Like a Hedge Fund and Trade Like Warren Buffett. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback; click here to send him an email.

TheStreet.com has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from TheStreet.com.

If you liked this article you might like

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup